Literature DB >> 30590304

The association between experiencing discrimination and physical and mental health among people who inject drugs.

Camila Couto E Cruz1, Caroline L Salom2, Paul Dietze3, Lucinda Burns4, Rosa Alati2.   

Abstract

BACKGROUND: Discrimination can be a daily issue in the lives of people who inject drugs (PWID). However, the extent to which discrimination is related to the health of PWID remains unclear.
METHODS: Data focusing on discrimination against PWID and potential health correlates were collected as part of the 2013 Illicit Drug Reporting System, a national survey with 887 PWID recruited in all Australian states and territories. Experience of discrimination, its setting, perceived reason and outcome, were self-reported by participants. The Kessler-10 scale and the mental component score of the Short Form 12-Item Health Survey were used to measure mental health. Physical health was assessed using the physical component score of the Short Form 12-Item Health Survey, specifically questions assessing injecting related problems and risk behaviour. Poisson and multinomial regression analyses were performed. Models were adjusted for socio-demographic and drug-related covariates.
FINDINGS: PWID reported experiencing discrimination in pharmacies, hospitals, government services and doctors/prescribers. The most commonly reported instances of discrimination were being refused service and experiencing abuse and/or violence. Experience of discrimination was associated with mental and physical health indicators. PWID who experienced discrimination were more likely to report high or very high mental distress (ARRR = 2.4, CI95 = 1.5-3.6) and mental health problems (ARRR = 1.4, CI95 = 1.2-1.7). The mental functioning (ARRR = 1.3, CI95 = 1.1-1.4) and physical functioning (ARRR = 1.1, CI95 = 1.1-1.4) of PWID, who experienced discrimination, were also more likely to be below Australian population mean scores.
CONCLUSION: Self-reported experience of discrimination was associated with poor mental and physical health amongst PWID.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Discrimination; People who inject drugs; Stigma

Mesh:

Year:  2018        PMID: 30590304     DOI: 10.1016/j.drugpo.2018.12.010

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  6 in total

1.  Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study.

Authors:  Heather Valerio; Maryam Alavi; David Silk; Carla Treloar; Marianne Martinello; Andrew Milat; Adrian Dunlop; Jo Holden; Charles Henderson; Janaki Amin; Phillip Read; Philippa Marks; Louisa Degenhardt; Jeremy Hayllar; David Reid; Carla Gorton; Thao Lam; Gregory J Dore; Jason Grebely
Journal:  Clin Infect Dis       Date:  2021-07-01       Impact factor: 9.079

2.  Drug use stigma, antiretroviral therapy use, and HIV viral suppression in a community-based sample of people with HIV who inject drugs.

Authors:  Eshan U Patel; Sunil S Solomon; Allison M McFall; Neia Prata Menezes; Cecília Tomori; Aylur K Srikrishnan; Muniratnam S Kumar; David D Celentano; Gregory M Lucas; Shruti H Mehta
Journal:  AIDS       Date:  2022-06-22       Impact factor: 4.632

3.  Discrimination, psychological functioning, and substance use among U.S. young adults aged 18-28, 2017.

Authors:  Dina M Jones; Katherine E Masyn; Claire Adams Spears
Journal:  Exp Clin Psychopharmacol       Date:  2021-08-16       Impact factor: 3.492

4.  Changes in Health-related Quality of Life for Hepatitis C Virus-Infected People Who Inject Drugs While on Opioid Agonist Treatment Following Sustained Virologic Response.

Authors:  Mirinda Ann Gormley; Matthew J Akiyama; Lior Rennert; Kerry A Howard; Brianna L Norton; Irene Pericot-Valverde; Sam Muench; Moonseong Heo; Alain H Litwin
Journal:  Clin Infect Dis       Date:  2022-05-03       Impact factor: 20.999

5.  Drug use stigma and its association with active hepatitis C virus infection and injection drug use behaviors among community-based people who inject drugs in India.

Authors:  Eshan U Patel; Sunil S Solomon; Gregory M Lucas; Allison M McFall; Cecília Tomori; Aylur K Srikrishnan; Muniratnam S Kumar; Oliver Laeyendecker; David D Celentano; David L Thomas; Thomas C Quinn; Shruti H Mehta
Journal:  Int J Drug Policy       Date:  2021-07-08

6.  Tracking Study on the Relapse and Aftercare Effect of Drug Patients Released From a Compulsory Isolated Detoxification Center.

Authors:  Nian Liu; Zekai Lu; Ying Xie
Journal:  Front Psychiatry       Date:  2022-01-17       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.